Long-term use of continuous subcutaneous insulin infusion

Diabetes Research and Clinical Practice

Volumn 74, Issue SUPPL. 2, 2006, Pages

  Pickup, John C ^a  

^a GUY S HOSPITAL   (United Kingdom)

Author keywords

Continuous subcutaneous insulin infusion; HbAlc; Insulin pump therapy; Intensified insulin therapy; Micovascular disease; Type 1 diabetes

Indexed keywords

HEMOGLOBIN A1C; INSULIN; INSULIN GLARGINE;

ARTICLE; CLINICAL TRIAL; CONTINUOUS INFUSION; DRUG INDICATION; GLUCOSE BLOOD LEVEL; HUMAN; HYPERGLYCEMIA; HYPOGLYCEMIA; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN INFUSION; INSULIN PUMP; LONG TERM CARE; MICROANGIOPATHY; RISK REDUCTION; TREATMENT INDICATION;

EID: 33845484451     PISSN: 01688227     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-8227(06)70008-0     Document Type: Article

References (8)

1. Pickup J., and Keen H. Continuous subcutaneous insulin infusion at 25 years. Evidence base for the expanding use of insulin pump therapy in type 1 diabetes. Diabetes Care 25 (2002) 593-598
2. Bode B.W., Steed R.D., and Davidson P.C. Reduction in severe hypoglycemia with long-term continuous subcutaneous insulin mfusion in type 1 diabetes. Diabetes Care 19 (1996) 324-327
3. Boland E.A., Grey M., Oesterle A., Fredrickson L., and Tamborlane W.V. Continuous subcutaneous insulin infusion. A new way to lower risk of severe hypoglycemia, improve metabolic control and enhance coping in adolescents with type 1 diabetes. Diabetes Care 22 (1999) 1799 1784
4. Pickup J.C., Mattock M.B., and Kerry S. Glycaemic control with continuous subcutaneous insulin infusion compared to intensive insulin injection therapy in type 1 diabetes: meta-analysis of randomised controlled trials. BMJ 324 (2002) 705-708
5. Pickup J.C., Kidd J., Burmiston S., and Yemane N. Effectiveness of continuous subcutaneous insulin infusion in hypoglycaemiaprone type 1 diabetes: implications for NICE guidelines. Pract Diabet Int 22 (2005) 10-14
6. J.C. Pickup, J. Kidd, S. Burmiston, N. Yemane, Determinants of glycaemic control in type 1 diabetes during intensified therapy with multiple daily insulin injections or continuous subcutaneous insulin infusion: importance of blood glucose variability. Diabet Metab Res Rev, in press.
7. Diabetes Control and Complications Trial Research Group. The absence of a glycemic threshold for the development of longterm complications: the perspective of the Diabetes Control and Complications Trial. Diabetes 45 (1996) 1289-1298
8. Warren E., Weatherley-Jones E., Chilcott J., and Beverley C. Systematic review and economic evaluation of a long-acting insulin analogue, insulin glargine. Health Technol Assess 8 No. 45 (2004) 1-57